Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 2 (2005), Issue 6 (June)

1. Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei.
   Biotechnol Lett, 27(7): 483-7. [Abstract] [Full-text]
2. Effect of des-aspartate-angiotensin I on the actions of angiotensin II in the isolated renal and mesenteric vasculature of hypertensive and STZ-induced diabetic rats.
   Regul Pept, 129(1): 213-9. [Abstract] [Full-text]
3. Diabetes in children and adolescents from ethnic minorities: barriers to education, treatment and good metabolic control.
   J Adv Nurs, 50(6): 576-82. [Abstract] [Full-text]
4. Hepatic vagotomy alters limbic and hypothalamic neuropeptide responses to insulin-dependent diabetes and voluntary lard ingestion.
   Eur J Neurosci, 21(10): 2733-42. [Abstract] [Full-text]
5. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study.
   Br J Cancer, 92(11): 2070-5. [Abstract] [Full-text]
6. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies.
   Br J Cancer, 92(11): 2076-83. [Abstract] [Full-text]
7. Does a central MHC gene in linkage disequilibrium with HLA-DRB1*0401 affect susceptibility to type 1 diabetes?
   Genes Immun, 6(4): 298-304. [Abstract] [Full-text]
8. Association of plasma homocysteine with serum interleukin-6 and C-peptide levels in patients with type 2 diabetes.
   Metabolism, 54(6): 809-14. [Abstract] [Full-text]
9. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
   Metabolism, 54(6): 800-8. [Abstract] [Full-text]
10. The intrarenal blood flow distribution and role of nitric oxide in diabetic rats.
    Metabolism, 54(6): 788-92. [Abstract] [Full-text]
11. Linkage study of the glucagon receptor gene with type 2 diabetes mellitus in Italians.
    Metabolism, 54(6): 786-7. [Abstract] [Full-text]
12. Inverse correlation between serum adiponectin concentration and hepatic lipid content in Japanese with type 2 diabetes.
    Metabolism, 54(6): 775-80. [Abstract] [Full-text]
13. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
    Metabolism, 54(6): 705-12. [Abstract] [Full-text]
14. Genetic epidemiology of diabetes.
    J Clin Invest, 115(6): 1431-9. [Abstract] [Full-text]
15. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.
    J Endocrinol, 185(3): 457-65. [Abstract] [Full-text]
16. The E23K variant in the Kir6.2 subunit of the ATP-sensitive K+ channel does not augment impaired glucose tolerance in Caribbean subjects with a family history of type 2 diabetes.
    J Endocrinol, 185(3): 439-44. [Abstract] [Full-text]
17. Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes.
    Am J Gastroenterol, 100(6): 1317-21. [Abstract] [Full-text]
18. Morphometric and quantitative evaluation of the NADH-diaphorase positive myenteric neurons of the jejunum of streptozotocin-diabetic rats supplemented with acetyl-L-carnitine.
    Anat Histol Embryol, 34(3): 154-8. [Abstract] [Full-text]
19. Website review: diabetes insight--www.diabetes-insight.info.
    Diabetes Technol Ther, 7(3): 573-80. [Abstract] [Full-text]
20. British internet-derived patient information on diabetes mellitus: is it readable?
    Diabetes Technol Ther, 7(3): 528-35. [Abstract] [Full-text]
21. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy.
    Diabetes Technol Ther, 7(3): 497-508. [Abstract] [Full-text]
22. Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes: a dose-ranging study.
    Diabetes Technol Ther, 7(3): 467-77. [Abstract] [Full-text]
23. Clinical assessment of near-infrared spectroscopy for noninvasive diabetes screening.
    Diabetes Technol Ther, 7(3): 456-66. [Abstract] [Full-text]
24. Real-time glucose sensing using transdermal fluid under continuous vacuum pressure in children with type 1 diabetes.
    Diabetes Technol Ther, 7(3): 448-55. [Abstract] [Full-text]
25. Response to nocturnal alarms using a real-time glucose sensor.
    Diabetes Technol Ther, 7(3): 440-7. [Abstract] [Full-text]
26. MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.
    Proc Natl Acad Sci U S A, 102(22): 7970-5. [Abstract] [Full-text]
27. FGF-21 as a novel metabolic regulator.
    J Clin Invest, 115(6): 1627-35. [Abstract] [Full-text]
28. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells.
    Proc Natl Acad Sci U S A, 102(22): 7964-9. [Abstract] [Full-text]
29. Detection of diabetic retinopathy: a comparison between red-free digital images and colour transparencies.
    Graefes Arch Clin Exp Ophthalmol, 243(5): 427-32. [Abstract] [Full-text]
30. The effect of intravitreal triamcinolone on diabetic macular oedema.
    Graefes Arch Clin Exp Ophthalmol, 243(5): 478-81. [Abstract] [Full-text]
31. Diabetes insipidus caused by isolated intracranial metatstases in patient with breast cancer.
    J Neurooncol, 73(1): 39-42. [Abstract] [Full-text]
32. Hepatic regeneration promotes engraftment of intraportally transplanted islet cells.
    Surgery, 137(6): 612-9. [Abstract] [Full-text]
33. Hypoglycemia during the 100-g oral glucose tolerance test: incidence and perinatal significance.
    Obstet Gynecol, 105(6): 1424-8. [Abstract] [Full-text]
34. Effects of pars plana vitrectomy on retrobulbar haemodynamics in diabetic retinopathy.
    Clin Experiment Ophthalmol, 33(3): 246-51. [Abstract] [Full-text]
35. Comparison of mean macular thickness using optical coherence tomography and visual acuity in diabetic retinopathy.
    Clin Experiment Ophthalmol, 33(3): 240-5. [Abstract] [Full-text]
36. Epitope analysis of insulin autoantibodies using recombinant Fab.
    Clin Exp Immunol, 140(3): 564-71. [Abstract] [Full-text]
37. Perspectives on clinic attendance, medication and foot-care among people with diabetes in the Torres Strait Islands and Northern Peninsula Area.
    Aust J Rural Health, 13(3): 172-7. [Abstract] [Full-text]
38. Glucose clearance is higher in arm than leg muscle in type 2 diabetes.
    J Physiol, 565: 555-62. [Abstract] [Full-text]
39. Diabetic neuropathy.
    Semin Neurol, 25(2): 168-73. [Abstract] [Full-text]
40. Cost of ambulatory care of diabetes mellitus: a study from north India.
    Postgrad Med J, 81(956): 391-5. [Abstract] [Full-text]
41. Detecting small-area similarities in the epidemiology of childhood acute lymphoblastic leukemia and diabetes mellitus, type 1: a Bayesian approach.
    Am J Epidemiol, 161(12): 1168-80. [Abstract] [Full-text]
42. The role of sorbitol pathway and treatment effect of aldose reductase inhibitor ONO2235 in the up-regulation of cardiac M2-muscarinic receptors in streptozotocin-induced diabetic rats.
    Neurosci Lett, 383(1): 131-5. [Abstract] [Full-text]
43. Alterations in antioxidant enzyme activities in the eyes, aorta and kidneys of diabetic rats relevant to the onset of oxidative stress.
    Life Sci, 77(7): 721-34. [Abstract] [Full-text]
44. Normalization of glucose post-transplantation of pig pancreatic anlagen into non-immunosuppressed diabetic rats depends on obtaining anlagen prior to embryonic day 35.
    Transpl Immunol, 14(2): 67-75. [Abstract] [Full-text]
45. Dietary fibre, glycaemic response, and diabetes.
    Mol Nutr Food Res, 49(6): 560-70. [Abstract] [Full-text]
46. Growth hormone binding protein and maternal body mass index in relation to placental growth hormone and insulin requirements during pregnancy in type 1 diabetic women.
    Growth Horm IGF Res, 15(3): 223-30. [Abstract] [Full-text]
47. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.
    Nat Med, 11(6): 645-52. [Abstract] [Full-text]
48. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.
    Ophthalmology, 112(6): 1086-91. [Abstract] [Full-text]
49. Persistent impaired glucose tolerance, insulin resistance, and beta-cell dysfunction were independent predictors of type 2 diabetes.
    J Clin Epidemiol, 58(7): 728-32. [Abstract] [Full-text]
50. High cumulative insulin exposure: a risk factor of atherosclerosis in type 1 diabetes?
    Atherosclerosis, 181(1): 185-92. [Abstract] [Full-text]
51. Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes.
    Atherosclerosis, 181(1): 109-14. [Abstract] [Full-text]
52. Dysregulation of the endothelial nitric oxide synthase-soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic rat.
    Atherosclerosis, 181(1): 69-73. [Abstract] [Full-text]
53. Changes in rhodopsin kinase and transducin in the rat retina in early-stage diabetes.
    Exp Eye Res, 80(6): 753-60. [Abstract] [Full-text]
54. The Belgrade childhood diabetes study: a multivariate analysis of risk determinants for diabetes.
    Eur J Public Health, 15(2): 117-22. [Abstract] [Full-text]
55. Antihyperglycaemic flavonoids from Syzygium samarangense (Blume) Merr. and Perry.
    Phytother Res, 19(3): 246-51. [Abstract] [Full-text]
56. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.
    Hum Reprod Update, 11(4): 375-90. [Abstract] [Full-text]
57. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
    Pharmacology, 74(3): 119-26. [Abstract] [Full-text]
58. Glycogen accumulation in renal tubules, a key morphological change in the diabetic rat kidney.
    Acta Diabetol, 42(2): 110-6. [Abstract] [Full-text]
59. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
    Acta Diabetol, 42(2): 104-9. [Abstract] [Full-text]
60. Prevalence of aspirin resistance in patients with type 2 diabetes.
    Acta Diabetol, 42(2): 99-103. [Abstract] [Full-text]
61. Anaesthesia-induced hyperglycaemia early in life is not predictive for development of diabetes in diabetes-prone BB rats.
    Acta Diabetol, 42(2): 95-8. [Abstract] [Full-text]
62. Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors.
    Acta Diabetol, 42(2): 87-94. [Abstract] [Full-text]
63. Influence of diabetes on peripheral bone mineral density in men: a controlled study.
    Acta Diabetol, 42(2): 82-6. [Abstract] [Full-text]
64. Oxidative stress in kidney and liver of alloxan-induced diabetic rabbits: effect of repaglinide.
    Acta Diabetol, 42(2): 75-81. [Abstract] [Full-text]
65. Bilateral, nearly simultaneous anterior ischemic optic neuropathy complicated by diabetes and bilateral, small, crowded optic discs.
    Jpn J Ophthalmol, 49(3): 235-8. [Abstract] [Full-text]
66. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes.
    Med Mol Morphol, 38(2): 84-91. [Abstract] [Full-text]
67. Deep neck infection in diabetic patients: comparison of clinical picture and outcomes with nondiabetic patients.
    Otolaryngol Head Neck Surg, 132(6): 943-7. [Abstract] [Full-text]
68. Influence of diabetes mellitus on the endovascular treatment of abdominal aortic aneurysms.
    J Endovasc Ther, 12(3): 288-96. [Abstract] [Full-text]
69. Chryseobacterium indologenes bacteraemia in a diabetic child.
    J Med Microbiol, 54: 677-80. [Abstract] [Full-text]
70. Malign cystic glucagonoma presented with diabetic ketoacidosis: case report with an update.
    Endocr Relat Cancer, 12(2): 449-54. [Abstract] [Full-text]
71. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass.
    Obes Surg, 15(5): 661-9. [Abstract] [Full-text]
72. Diabetes self-management among low-income Spanish-speaking patients: a pilot study.
    Ann Behav Med, 29(3): 225-35. [Abstract] [Full-text]
73. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice.
    Circ Res, 96(11): 1178-84. [Abstract] [Full-text]
74. Two-stage community-based screening model for estimating prevalence of diabetic polyneuropathy (KCIS no. 6).
    Neuroepidemiology, 25(1): 1-7. [Abstract] [Full-text]
75. Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.
    Endocrinology, 146(7): 2942-51. [Abstract] [Full-text]
76. Association of humoral immunity to human Hsp60 with the IL-6 gene polymorphism C-174G in patients with type 2 diabetes and controls.
    Horm Metab Res, 37(4): 257-63. [Abstract] [Full-text]
77. Pentosidine plasma levels and relation with metabolic control in diabetic patients.
    Horm Metab Res, 37(4): 252-6. [Abstract] [Full-text]
78. Development of a questionnaire to measure heart disease risk knowledge in people with diabetes: the Heart Disease Fact Questionnaire.
    Patient Educ Couns, 58(1): 82-7. [Abstract] [Full-text]
79. Prevalence of left ventricular diastolic dysfunction in obese persons with and without diabetes mellitus.
    Am J Cardiol, 95(12): 1527-8. [Abstract] [Full-text]
80. Prevalence of silent myocardial ischemia in persons with diabetes mellitus or impaired glucose tolerance and association of hemoglobin A1c with prevalence of silent myocardial ischemia.
    Am J Cardiol, 95(12): 1472-4. [Abstract] [Full-text]
81. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients.
    Arch Med Res, 36(4): 376-81. [Abstract] [Full-text]
82. Anti-diabetic effect of ginsenoside Re in ob/ob mice.
    Biochim Biophys Acta, 1740(3): 319-25. [Abstract] [Full-text]
83. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.
    Biochim Biophys Acta, 1740(2): 313-7. [Abstract] [Full-text]
84. An innovative Australian point-of-care model for urine albumin: creatinine ratio testing that supports diabetes management in indigenous medical services and has international application.
    Ann Clin Biochem, 42: 208-15. [Abstract] [Full-text]
85. HbA1c predicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose.
    Ann Clin Biochem, 42: 193-5. [Abstract] [Full-text]
86. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
    Eur J Clin Invest, 35(6): 369-74. [Abstract] [Full-text]
87. Amino acid-dependent modulation of glucose metabolism in humans.
    Eur J Clin Invest, 35(6): 351-4. [Abstract] [Full-text]
88. Photocoagulation for diabetic retinopathy: determinants of patient satisfaction and the patient-provider relationship.
    Acta Ophthalmol Scand, 83(3): 316-21. [Abstract] [Full-text]
89. Effects of garlic oil and diallyl trisulfide on glycemic control in diabetic rats.
    Eur J Pharmacol, 516(2): 165-73. [Abstract] [Full-text]
90. Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist.
    Biochem Biophys Res Commun, 332(4): 927-33. [Abstract] [Full-text]
91. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
    Public Health, 119(8): 711-20. [Abstract] [Full-text]
92. Reactive carbonyls and polyunsaturated fatty acids produce a hydroxyl radical-like species: a potential pathway for oxidative damage of retinal proteins in diabetes.
    J Biol Chem, 280(24): 22706-14. [Abstract] [Full-text]
93. Localization of the GLUT8 glucose transporter in murine kidney and regulation in vivo in nondiabetic and diabetic conditions.
    Am J Physiol Renal Physiol, 289(1): F186-93. [Abstract] [Full-text]
94. HDL-C and the diabetic patient: target for therapeutic intervention?
    Diabetes Res Clin Pract, 68: S36-42. [Abstract] [Full-text]
95. The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?
    Diabetes Res Clin Pract, 68: S3-14. [Abstract] [Full-text]
96. Effective care of patients with type 2 diabetes and dyslipidemia: a nurse's perspective.
    Diabetes Res Clin Pract, 68: S23-7. [Abstract] [Full-text]
97. Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes.
    Am J Ophthalmol, 139(6): 1042-50. [Abstract] [Full-text]
98. The cost of medical care for patients with diabetes, hypertension and both conditions: does alcohol use play a role?
    J Intern Med, 258(1): 45-54. [Abstract] [Full-text]
99. Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes.
    J Intern Med, 258(1): 38-44. [Abstract] [Full-text]
100. Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines.
     Eur J Cancer Care (Engl), 14(3): 244-8. [Abstract] [Full-text]
101. Long-term risk reduction: who needs treatment?
     Diabetes Res Clin Pract, 68: S15-22. [Abstract] [Full-text]
102. Relaxin adenylyl cyclase system of pregnant women with diabetes: functional defects in insulin and relaxin adenylyl cyclase signaling systems in myometrium of pregnant women with type 1 diabetes.
     Ann N Y Acad Sci, 1041: 446-8. [Abstract] [Full-text]
103. Computer classification of nonproliferative diabetic retinopathy.
     Arch Ophthalmol, 123(6): 759-64. [Abstract] [Full-text]
104. Gene-diet interaction in relation to the prevention of obesity and type 2 diabetes: evidence from the Finnish Diabetes Prevention Study.
     Nutr Metab Cardiovasc Dis, 15(3): 225-33. [Abstract] [Full-text]
105. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
     Nutr Metab Cardiovasc Dis, 15(3): 204-11. [Abstract] [Full-text]
106. Herbal remedies in the management of diabetes: lessons learned from the study of ginseng.
     Nutr Metab Cardiovasc Dis, 15(3): 149-60. [Abstract] [Full-text]
107. Reduced urinary excretion of sulfated polysaccharides in diabetic rats.
     Biochim Biophys Acta, 1741(1): 30-41. [Abstract] [Full-text]
108. Treatment regimen determines the relationship between depression and glycemic control.
     Diabetes Res Clin Pract, 69(1): 78-80. [Abstract] [Full-text]
109. Metabolic response to oral lipid overload in diabetes and impaired glucose tolerance.
     Diabetes Res Clin Pract, 69(1): 36-43. [Abstract] [Full-text]
110. Characteristics of childhood and adult-onset type 1 diabetes in a multi-ethnic population.
     Diabetes Res Clin Pract, 69(1): 22-8. [Abstract] [Full-text]
111. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy.
     Diabetes Res Clin Pract, 69(1): 14-21. [Abstract] [Full-text]
112. A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome.
     Diabetes Res Clin Pract, 69(1): 5-13. [Abstract] [Full-text]
113. Possible novel index determined by the glucose clamp test for selection of a suitable therapy for each type 2 diabetic patient.
     Diabetes Res Clin Pract, 69(1): 1-4. [Abstract] [Full-text]
114. Can type 2 diabetes mellitus be considered preventable?
     Diabetes Res Clin Pract, 68: S73-81. [Abstract] [Full-text]
115. Role of endothelial dysfunction in the development of cardiorenal syndrome in patients with type 1 diabetes mellitus.
     Diabetes Res Clin Pract, 68: S65-72. [Abstract] [Full-text]
116. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
     Diabetes Res Clin Pract, 68: S54-9. [Abstract] [Full-text]
117. Can the atherosclerosis prevention targets be achieved in type 2 diabetes?
     Diabetes Res Clin Pract, 68: S48-51. [Abstract] [Full-text]
118. Prevention and treatment of diabetic nephropathy.
     Diabetes Res Clin Pract, 68: S36-42. [Abstract] [Full-text]
119. Early use of insulin in type 2 diabetes.
     Diabetes Res Clin Pract, 68: S30-5. [Abstract] [Full-text]
120. Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies.
     Diabetes Res Clin Pract, 68: S22-9. [Abstract] [Full-text]
121. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis.
     Diabetes Res Clin Pract, 68: S2-9. [Abstract] [Full-text]
122. Genetics of type 2 diabetes mellitus.
     Diabetes Res Clin Pract, 68: S10-21. [Abstract] [Full-text]
123. Can murine diabetic nephropathy be separated from superimposed acute renal failure?
     Kidney Int, 68(1): 391-8. [Abstract] [Full-text]
124. A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy.
     Kidney Int, 68(1): 285-92. [Abstract] [Full-text]
125. Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes.
     Kidney Int, 68(1): 271-7. [Abstract] [Full-text]
126. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns.
     Kidney Int, 68(1): 193-205. [Abstract] [Full-text]
127. Period of gestational diabetes mellitus diagnosis and maternal and fetal morbidity.
     Acta Obstet Gynecol Scand, 84(7): 622-7. [Abstract] [Full-text]
128. Supplementation with N-acetylcysteine and taurine failed to restore glutathione content in liver of streptozotocin-induced diabetics rats but protected from oxidative stress.
     Biochim Biophys Acta, 1741(1): 48-54. [Abstract] [Full-text]
129. A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia.
     Diabetes Res Clin Pract, 69(1): 44-51. [Abstract] [Full-text]
130. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.
     Biochim Biophys Acta, 1741(1): 206-14. [Abstract] [Full-text]
131. Isolated type 2 diabetes mellitus causes myocardial dysfunction that becomes worse in the presence of cardiovascular diseases: results of the myocardial doppler in diabetes (MYDID) study 1.
     Cardiology, 103(4): 189-95. [Abstract] [Full-text]
132. Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia.
     Am J Physiol Regul Integr Comp Physiol, 289(1): R235-46. [Abstract] [Full-text]
133. Do mass media affect Medicare beneficiaries' use of diabetes services?
     Am J Prev Med, 29(1): 51-3. [Abstract] [Full-text]
134. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation.
     J Peripher Nerv Syst, 10(2): 202-8. [Abstract] [Full-text]
135. Impaired peripheral nerve regeneration in diabetes mellitus.
     J Peripher Nerv Syst, 10(2): 144-57. [Abstract] [Full-text]
136. Diabetic end-stage renal disease in the indigenous population of the Commonwealth of the Northern Mariana Islands.
     Nephrology (Carlton), 10(3): 291-5. [Abstract] [Full-text]
137. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.
     N Engl J Med, 352(24): 2477-86. [Abstract] [Full-text]
138. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort.
     Diabetologia, 48(6): 1126-34. [Abstract] [Full-text]
139. Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.
     Diabetologia, 48(6): 1093-104. [Abstract] [Full-text]
140. Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain.
     Diabetologia, 48(6): 1135-41. [Abstract] [Full-text]
141. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects.
     Diabetologia, 48(6): 1088-92. [Abstract] [Full-text]
142. Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment.
     Diabetologia, 48(6): 1105-13. [Abstract] [Full-text]
143. Abnormal viscoelastic behaviour of passive ankle joint movement in diabetic patients: an early or a late complication?
     Diabetologia, 48(6): 1225-8. [Abstract] [Full-text]
144. Genome-wide linkage scans for prediabetes phenotypes in response to 20 weeks of endurance exercise training in non-diabetic whites and blacks: the HERITAGE Family Study.
     Diabetologia, 48(6): 1142-9. [Abstract] [Full-text]
145. The influence of type 2 diabetes on fibrin structure and function.
     Diabetologia, 48(6): 1198-206. [Abstract] [Full-text]
146. Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus.
     Diabetologia, 48(6): 1168-72. [Abstract] [Full-text]
147. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.
     Diabetologia, 48(6): 1207-15. [Abstract] [Full-text]
148. Birthweight and risk of type 1 diabetes in children and young adults: a population-based register study.
     Diabetologia, 48(6): 1114-7. [Abstract] [Full-text]
149. An immune origin of type 2 diabetes?
     Diabetologia, 48(6): 1038-50. [Abstract] [Full-text]
150. Alcohol consumption and type 2 diabetes Meta-analysis of epidemiological studies indicates a U-shaped relationship.
     Diabetologia, 48(6): 1051-4. [Abstract] [Full-text]
151. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.
     Glycobiology, 15(7): 16R-28R. [Abstract] [Full-text]
152. Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.
     Am J Physiol Endocrinol Metab, 289(1): E151-9. [Abstract] [Full-text]
153. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.
     Am J Physiol Endocrinol Metab, 289(1): E113-22. [Abstract] [Full-text]
154. Life versus disease in difficult diabetes care: conflicting perspectives disempower patients and professionals in problem solving.
     Qual Health Res, 15(6): 750-65. [Abstract] [Full-text]
155. CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis.
     Am J Epidemiol, 162(1): 3-16. [Abstract] [Full-text]
156. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin.
     Brain Res, 1048(1): 108-15. [Abstract] [Full-text]
157. Endothelial dysfunction in Type 2 diabetes correlates with deregulated expression of the tail-anchored membrane protein SLMAP.
     Am J Physiol Heart Circ Physiol, 289(1): H206-11. [Abstract] [Full-text]
158. The impact of the Health Technology Board for Scotland's grading model on referrals to ophthalmology services.
     Br J Ophthalmol, 89(7): 891-6. [Abstract] [Full-text]
159. Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay.
     Br J Ophthalmol, 89(7): 871-3. [Abstract] [Full-text]
160. "Light" versus "classic" laser treatment for clinically significant diabetic macular oedema.
     Br J Ophthalmol, 89(7): 864-70. [Abstract] [Full-text]
161. Embolization of a ruptured pseudoaneurysm with massive hemorrhage following pancreas transplantation: a case report.
     Transplant Proc, 37(5): 2275-7. [Abstract] [Full-text]
162. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
     Transplant Proc, 37(5): 2266-9. [Abstract] [Full-text]
163. The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy.
     Transplant Proc, 37(5): 2263-5. [Abstract] [Full-text]
164. Diabetic retinopathy before and after renal transplantation: a longitudinal study.
     Transplant Proc, 37(5): 2077-9. [Abstract] [Full-text]
165. Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice.
     Life Sci, 77(9): 980-90. [Abstract] [Full-text]
166. Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial.
     J Am Coll Cardiol, 45(12): 1932-8. [Abstract] [Full-text]
167. Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study.
     J Am Coll Cardiol, 45(12): 1925-31. [Abstract] [Full-text]
168. Type 2 diabetes mellitus: a cardiovascular perspective.
     Int J Clin Pract, 59(7): 798-816. [Abstract] [Full-text]
169. Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.
     Int J Clin Pract, 59(7): 746-50. [Abstract] [Full-text]
170. Patient management of long-term continuous subcutaneous insulin infusion.
     J Adv Nurs, 51(2): 112-8. [Abstract] [Full-text]
171. Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents.
     Br J Clin Pharmacol, 60(1): 103-6. [Abstract] [Full-text]
172. From congenital hyperinsulinism to diabetes mellitus: the role of pancreatic beta-cell KATP channels.
     Pediatr Diabetes, 6(2): 103-13. [Abstract] [Full-text]
173. Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates.
     Pediatr Diabetes, 6(2): 95-9. [Abstract] [Full-text]
174. Diabetic ketoacidosis, hyperosmolarity and hypernatremia: are high-carbohydrate drinks worsening initial presentation?
     Pediatr Diabetes, 6(2): 90-4. [Abstract] [Full-text]
175. Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children.
     Pediatr Diabetes, 6(2): 84-9. [Abstract] [Full-text]
176. Increased incidence and severity of diabetic ketoacidosis among uninsured children with newly diagnosed type 1 diabetes mellitus.
     Pediatr Diabetes, 6(2): 79-83. [Abstract] [Full-text]
177. Clinical presentation of type 1 diabetes.
     Pediatr Diabetes, 6(2): 75-8. [Abstract] [Full-text]
178. Predictors of glucose control in children and adolescents with type 1 diabetes mellitus.
     Pediatr Diabetes, 6(2): 69-74. [Abstract] [Full-text]
179. Haplotype structure and phylogenetic shadowing of a hypervariable region in the CAPN10 gene.
     Hum Genet, 117(2): 258-66. [Abstract] [Full-text]
180. The clinical potential of chemokine receptor antagonists.
     Pharmacol Ther, 107(1): 44-58. [Abstract] [Full-text]
181. Effect of diabetes on aortic nitric oxide synthesis in spontaneously hypertensive rats; does captopril modulate this effect?
     Life Sci, 77(9): 1003-14. [Abstract] [Full-text]
182. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.
     Eur Heart J, 26(13): 1255-61. [Abstract] [Full-text]
183. Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
     J Pharmacol Exp Ther, 314(1): 191-200. [Abstract] [Full-text]
184. Is normal gastric emptying a predictor of normal gastric function?
     Nuklearmedizin, 44(3): 81-5. [Abstract] [Full-text]
185. Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals.
     Pharmacol Res, 52(2): 162-6. [Abstract] [Full-text]
186. Atorvastatin reduces the plasma lipids and oxidative stress but did not reverse the inhibition of prostacyclin generation by aortas in streptozotocin diabetic rats.
     Prostaglandins Other Lipid Mediat, 76(1): 59-73. [Abstract] [Full-text]
187. Treatment effects model for assessing disease management: measuring outcomes and strengthening program management.
     Dis Manag, 8(3): 155-68. [Abstract] [Full-text]
188. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats.
     Int J Pharm, 298(1): 176-85. [Abstract] [Full-text]
189. Duloxetine vs. placebo in patients with painful diabetic neuropathy.
     Pain, 116(1): 109-18. [Abstract] [Full-text]
190. The role of vitamin D in protecting type 1 diabetes mellitus.
     Diabetes Metab Res Rev, 21(4): 338-46. [Abstract] [Full-text]
191. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus.
     Diabetes Metab Res Rev, 21(4): 332-7. [Abstract] [Full-text]
192. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds.
     Clin Sci (Lond), 109(1): 83-95. [Abstract] [Full-text]
193. No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes.
     Diabetes Metab Res Rev, 21(4): 376-81. [Abstract] [Full-text]
194. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes.
     Diabetes Metab Res Rev, 21(4): 347-52. [Abstract] [Full-text]
195. Risk of type 1 diabetes in childhood and maternal age at delivery, interaction with ACP1 and sex.
     Diabetes Metab Res Rev, 21(4): 353-8. [Abstract] [Full-text]
196. Endothelin-mediated remodeling in aortas of diabetic rats.
     Diabetes Metab Res Rev, 21(4): 367-75. [Abstract] [Full-text]
197. Secretin-stimulated amylase release into blood is impaired in type 1 diabetes mellitus.
     Horm Metab Res, 37(5): 326-30. [Abstract] [Full-text]
198. Big infants in the neonatal intensive care unit.
     Am J Obstet Gynecol, 192(6): 1948-53; discussion 1953-5. [Abstract] [Full-text]
199. Overweight and obese in gestational diabetes: the impact on pregnancy outcome.
     Am J Obstet Gynecol, 192(6): 1768-76. [Abstract] [Full-text]
200. Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy.
     J Pharm Pharmacol, 57(6): 773-80. [Abstract] [Full-text]
201. Needlestick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study.
     Curr Med Res Opin, 21(5): 741-7. [Abstract] [Full-text]
202. Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel.
     Curr Med Res Opin, 21(5): 665-82. [Abstract] [Full-text]
203. Emerging trends in ocular telemedicine: the diabetic retinopathy model.
     J Telemed Telecare, 11(4): 163-6. [Abstract] [Full-text]
204. Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus.
     J Hum Hypertens, 19(7): 551-7. [Abstract] [Full-text]
205. Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents.
     J Pediatr, 146(6): 751-8. [Abstract] [Full-text]
206. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
     N Engl J Med, 352(25): 2598-608. [Abstract] [Full-text]
207. Inhaled insulin for diabetes mellitus.
     Am J Health Syst Pharm, 62(13): 1359-64. [Abstract] [Full-text]
208. Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study.
     Pain Med, 6(3): 225-34. [Abstract] [Full-text]
209. Haplotype construction of the FRDA gene and evaluation of its role in type II diabetes.
     Eur J Hum Genet, 13(7): 849-55. [Abstract] [Full-text]
210. Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.
     Exp Clin Endocrinol Diabetes, 113(6): 324-30. [Abstract] [Full-text]
211. A heteroplasmic mitochondrial DNA 3310 mutation in the ND1 gene in a patient with type 2 diabetes, hypertrophic cardiomyopathy, and mental retardation.
     Exp Clin Endocrinol Diabetes, 113(6): 318-23. [Abstract] [Full-text]
212. IFN-gamma low production capacity in type 1 diabetes mellitus patients at onset of disease.
     Exp Clin Endocrinol Diabetes, 113(6): 313-7. [Abstract] [Full-text]
213. Postanalytical external quality assessment of blood glucose and hemoglobin A1c: an international survey.
     Clin Chem, 51(7): 1145-53. [Abstract] [Full-text]
214. No consistent association between birthweight and parental risk of diabetes and cardiovascular disease.
     Diabet Med, 22(7): 950-3. [Abstract] [Full-text]
215. Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion.
     Diabet Med, 22(7): 946-9. [Abstract] [Full-text]
216. Depression in Croatian Type 2 diabetic patients: prevalence and risk factors. A Croatian survey from the European Depression in Diabetes (EDID) Research Consortium.
     Diabet Med, 22(7): 942-5. [Abstract] [Full-text]
217. Management of incidental hyperglycaemia in acute medical emergencies.
     Diabet Med, 22(7): 937-41. [Abstract] [Full-text]
218. Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh.
     Diabet Med, 22(7): 931-6. [Abstract] [Full-text]
219. Fetal erythrocyte membrane lipids modification: preliminary observation of an early sign of compromised insulin sensitivity in offspring of gestational diabetic women.
     Diabet Med, 22(7): 914-20. [Abstract] [Full-text]
220. Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?
     Diabet Med, 22(7): 907-13. [Abstract] [Full-text]
221. Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control.
     Diabet Med, 22(7): 900-6. [Abstract] [Full-text]
222. Physical activity and energy intake in adolescent girls with Type 1 diabetes.
     Diabet Med, 22(7): 893-9. [Abstract] [Full-text]
223. Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with Type 1 diabetes.
     Diabet Med, 22(7): 889-92. [Abstract] [Full-text]
224. ADVANCE--Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline.
     Diabet Med, 22(7): 882-8. [Abstract] [Full-text]
225. Lower plasma triglycerides are associated with increased need for insulin requirement in poorly controlled Type 2 diabetic patients.
     Diabet Med, 22(7): 877-81. [Abstract] [Full-text]
226. Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients.
     Diabet Med, 22(7): 871-6. [Abstract] [Full-text]
227. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
     Diabet Med, 22(7): 863-70. [Abstract] [Full-text]
228. Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin.
     Diabet Med, 22(7): 850-7. [Abstract] [Full-text]
229. Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service.
     Diabet Med, 22(7): 842-9. [Abstract] [Full-text]
230. An assessment of the coverage of a district-wide diabetic retinopathy screening service.
     Diabet Med, 22(7): 840-1. [Abstract] [Full-text]
231. Screening for diabetes in Indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease.
     Diabet Med, 22(7): 833-9. [Abstract] [Full-text]
232. Nutrition in patients with Type 2 diabetes: are low-carbohydrate diets effective, safe or desirable?
     Diabet Med, 22(7): 821-32. [Abstract] [Full-text]
233. Capnocytophaga spp. in periodontitis patients manifesting diabetes mellitus.
     J Periodontol, 76(2): 194-203. [Abstract] [Full-text]
234. Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
     Clin Chem, 51(7): 1185-91. [Abstract] [Full-text]
235. Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis.
     Clin Exp Nephrol, 9(2): 164-9. [Abstract] [Full-text]
236. Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose.
     Clin Exp Nephrol, 9(2): 114-21. [Abstract] [Full-text]
237. The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping.
     Invest Ophthalmol Vis Sci, 46(7): 2620-6. [Abstract] [Full-text]
238. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I.
     Invest Ophthalmol Vis Sci, 46(7): 2328-33. [Abstract] [Full-text]
239. Overnight thickness variation in diabetic macular edema.
     Invest Ophthalmol Vis Sci, 46(7): 2313-6. [Abstract] [Full-text]
240. Comparison of effectiveness of cardiac resynchronization therapy in patients with versus without diabetes mellitus.
     Am J Cardiol, 96(1): 108-11. [Abstract] [Full-text]
241. Prognostic value of exercise echocardiography in patients with diabetes mellitus and known or suspected coronary artery disease.
     Am J Cardiol, 96(1): 9-12. [Abstract] [Full-text]
242. Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.
     Clin Ther, 27(5): 554-67. [Abstract] [Full-text]
243. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
     Life Sci, 77(10): 1130-9. [Abstract] [Full-text]
244. Dynamic contrast enhanced MRI in patients with diabetic macular edema: initial results.
     Exp Eye Res, 81(1): 97-102. [Abstract] [Full-text]
245. SiRNA strategy against overexpression of extracellular matrix in diabetic retinopathy.
     Exp Eye Res, 81(1): 32-7. [Abstract] [Full-text]
246. Nephrolithiasis complicating treatment of diabetes insipidus.
     Urol Res, 33(3): 244-6. [Abstract] [Full-text]
247. Prevalence of depression among elderly Chinese with diabetes.
     Int J Geriatr Psychiatry, 20(6): 570-5. [Abstract] [Full-text]
248. The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy.
     Nitric Oxide, 13(1): 88-92. [Abstract] [Full-text]
249. Structured dietary advice incorporating walnuts achieves optimal fat and energy balance in patients with type 2 diabetes mellitus.
     J Am Diet Assoc, 105(7): 1087-96. [Abstract] [Full-text]
250. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
     Arch Intern Med, 165(12): 1410-9. [Abstract] [Full-text]
251. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
     Arch Intern Med, 165(12): 1401-9. [Abstract] [Full-text]
252. Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus.
     Arch Intern Med, 165(12): 1337-44. [Abstract] [Full-text]
253. External causes of metabolic disorders.
     Emerg Med Clin North Am, 23(3): 827-41, x. [Abstract] [Full-text]
254. Hyperosmolar hyperglycemic state.
     Emerg Med Clin North Am, 23(3): 629-48, vii. [Abstract] [Full-text]
255. Diabetic ketoacidosis.
     Emerg Med Clin North Am, 23(3): 609-28, vii. [Abstract] [Full-text]
256. Validation of the Australian/English version of the Diabetes Management Self-Efficacy Scale.
     Int J Nurs Pract, 11(4): 177-84. [Abstract] [Full-text]
257. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes.
     Biochem Biophys Res Commun, 333(3): 679-85. [Abstract] [Full-text]
258. Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggregation in platelets from type 2 diabetic patients.
     Biochem Biophys Res Commun, 333(3): 794-802. [Abstract] [Full-text]
259. The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy.
     Eur Heart J, 26(14): 1369-78. [Abstract] [Full-text]
260. Biokinetics of buccal spray insulin in patients with type 1 diabetes.
     Metabolism, 54(7): 930-4. [Abstract] [Full-text]
261. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes.
     Metabolism, 54(7): 866-75. [Abstract] [Full-text]
262. Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice.
     Metabolism, 54(7): 848-55. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.